Relapsed and/or Refractory Non-Hodgkin Lymphoma Study
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
- Status
- COMPLETED
- Phase
- PHASE2
T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL
- Status
- COMPLETED
- Phase
- PHASE1
Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD
- Status
- COMPLETED
- Phase
- PHASE2
Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877
- Status
- TERMINATED
- Phase
- PHASE1
The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.
- Status
- UNKNOWN
- Phase
- N/A
Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells
- Status
- COMPLETED
- Phase
- PHASE3
Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women
- Status
- COMPLETED
- Phase
- N/A
The Second Multicenter Hemophilia Cohort Study
- Status
- COMPLETED
- Phase
- N/A
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2